EDGAR·FLOW

Most material SEC filings — July 21, 2026

12 filings analyzed. Top movers: Utz Brands, Inc., VYNE Therapeutics Inc., VisionWave Holdings, Inc., Aether Holdings, Inc., Twenty One Capital, Inc..
8-K Utz Brands, Inc.
Intersnack Group GmbH Co. KG will acquire all outstanding Class A shares of Utz Brands for $14.25 per share in cash, representing a 91% premium to the July 20, 2026 closing price and an enterprise value of ~$2.9 billion. Upon closing, Utz becomes private with Rice and Lissette Family and Intersnack each owning 50%. Transaction financed by ~$920M Intersnack cash, $1.1B term loan, $250M ABL facility, and family rollover equity; expected to close Q4 2026 subject to stockholder approval (family committed ~42% of shares) and regulatory conditions.
▲ Likely positive · significance 95 · 8-K Agent
8-K VYNE Therapeutics Inc.
VYNE Therapeutics is merging with Yarrow Bioscience (closing expected July 24, 2026). VYNE Board approved a 1-for-50 reverse stock split, reducing outstanding shares from 33.4M to 0.7M. VYNE shareholders receive a special cash dividend of $17.3 million aggregate ($0.40242 per share based on 42.99M shares outstanding as of July 20, 2026), payable July 23, 2026. Post-merger combined company will trade under ticker YARW on Nasdaq Capital Market with approximately 2.7M shares outstanding (33.6M fully diluted).
— Neutral · significance 92 · 8-K Agent
8-K VisionWave Holdings, Inc.
On July 20, 2026, VisionWave Holdings issued a $10M convertible debenture (VWAV-4) to YA II PN, Ltd. at 5% interest (18% upon default), with monthly installment payments of $1.75M aggregate principal starting December 2026, maturity July 2027. Holder receives 1.8M warrants at $5/share exercise price. Conversion price fixed at $5/share; conversion capped at 4.99% ownership; dilutive issuances trigger price reductions. Standby equity purchase agreement (SEPA) coordinates with advance repayments. Second $5M tranche closes upon registration statement effectiveness.
▼ Likely negative · significance 78 · 8-K Agent
8-K Aether Holdings, Inc.
Aether Compute LLC secured an exclusive white-label distribution agreement for Virtual Grid's modular compute-energy pods (AetherPod VG100) across Southeast Asia, plus FOMA software licensing. Aether Holdings concurrently invested US$360,000 in Virtual Grid equity (176,412 shares at C$2.864692/share valuation implying US$25M pre-money) plus 176,412 warrants (5-year, same strike). FOMA royalties: 6% of direct compute revenue; 3% for operator sublicensing. 12-month lock-up on Aether shares; down-round true-up protection if Virtual Grid raises below US$25M within 24 months.
▲ Likely positive · significance 78 · 8-K Agent
8-K Twenty One Capital, Inc.
Jack Mallers resigned as Co-Founder and CEO of Twenty One Capital effective July 20, 2026, receiving $1.57M in cash ($420,455.39 for 80,393 vested RSUs at $5.23/share plus $1,151,046.48 for repurchased shares) and retaining 1,522,407 vested stock options at $14.43/share exercisable for 90 days. Raphael Zagury, founder of Elektron Energy (Bitcoin mining), was appointed CEO on the same date with $600K annual base salary, up to $700K annual bonus, and equity incentives. The company simultaneously announced Strike (Mallers' payments fintech) will remain independent rather than merge with Twenty One, and the proposed Elektron acquisition remains under preliminary evaluation.
▼ Likely negative · significance 72 · 8-K Agent
8-K ICAHN ENTERPRISES L.P.
Icahn Enterprises agreed to sell Pep Boys (≈800 locations) to Mavis Tire Express for approximately $700 million in cash. Icahn retains Pep Boys' owned real estate, AAMCO Transmissions, and Precision Tune Auto Care. The transaction is expected to close in the coming months, subject to customary closing conditions.
▲ Likely positive · significance 72 · 8-K Agent
8-K Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics announced a structured partnering process to out-license or co-develop its three late-stage cardiac assets: CAD-1005 (Phase 3-ready 12-LOX inhibitor for HIT, showing 25% absolute reduction in thrombotic events in Phase 2 data presented at ISTH 2026), frunexian (Phase 2-ready Factor XIa inhibitor for pre-operative HIT), and tecarfarin (Phase 3-ready oral anticoagulant for orphan indications including Kawasaki disease). No financial terms, counterparties, or timelines were disclosed. The company is pivoting to a capital-efficient, partnership-driven model rather than independent development.
— Neutral · significance 72 · 8-K Agent
8-K INTELLIGENT BIO SOLUTIONS INC.
Intelligent Bio Solutions (market cap ~$6.6M) announced completion of precision testing on its Intelligent Fingerprinting Drug Screening System for opiate detection. Testing comprised 1,600+ tests across three production runs and three independent sites, confirming reproducible performance. Results will support the company's FDA 510(k) submission for U.S. market clearance, targeting entry into a multi-billion-dollar drug screening market.
▲ Likely positive · significance 72 · 8-K Agent
8-K FORWARD AIR CORP
Forward Air entered into a non-binding MOU on July 20, 2026 with one of its largest customers regarding service transition discussions disclosed May 7, 2026. The Company expects to retain at least 50% (≈$125M) of the ~$250M annual revenue from this customer, with potential to retain up to 75% (≈$187.5M), with contract extension of at least 2 years. Service transitions to other providers begin later 2026, predominantly in December 2026 and throughout 2027.
— Neutral · significance 68 · 8-K Agent
8-K Sabra Health Care REIT, Inc.
Sabra entered into letters of intent to re-tenant all 26 Avamere properties: 22 to Cascadia Healthcare subsidiaries and 4 to an existing tenant. Combined annualized cash rent will increase ~30% from $41M to $53M (annualized), with transaction closing expected H2 2026. Separately, Sabra settled a $300M RCA mortgage for $200M (closed June 30, 2026), reducing leverage from 5.0x to 4.8x Net Debt/EBITDA pro forma. Full-year 2026 Normalized FFO guidance raised to $1.53–$1.55/share (7% midpoint growth vs. 2025) and Normalized AFFO to $1.59–$1.61/share (8% growth).
▲ Likely positive · significance 68 · 8-K Agent
8-K Fatpipe Inc/UT
FatPipe Inc (NASDAQ: FATN) announced July 21, 2026 award of a $7 million contract to provide SD-WAN network edge products and monitoring services to schools. The contract involves deploying FatPipe's technology across geographically distributed public-sector networks to improve network availability, visibility, and digital learning platform access. No revenue recognition timeline, payment terms, or contract duration details were disclosed.
▲ Likely positive · significance 68 · 8-K Agent
8-K HASBRO, INC.
Hasbro reported Q2 2026 revenue of $1.14B (+16% YoY), driven by Wizards of the Coast segment growing 27% with Magic: The Gathering exceeding $500M in quarterly revenue for the first time. The company raised full-year 2026 guidance to revenue growth of 5–7% (from 3–5%), adjusted operating margin to 25–26% (from 24–25%), and adjusted EBITDA to $1.45–$1.50B (from $1.40–$1.45B). The company took a $56M impairment on digital games, incurred $11M in direct costs from a March 2026 network breach (estimated $25M revenue impact), returned $133M to shareholders via dividends and buybacks ($55M share repurchase authorization deployed), and deployed $55M toward debt reduction.
▲ Likely positive · significance 62 · 8-K Agent
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.